Skip to main content
. 2017 May 24;2017:9456785. doi: 10.1155/2017/9456785

Figure 3.

Figure 3

The rat serum transaminases levels assayed at 2 h, 4 h, 24 h, 48 h, and 72 h after oral administration of PMR (x-±s,n=5). (a) and (b) for ALT level; (c) and (d) for AST level; (a) and (c) for CYP1A2 inhibited group; (b) and (d) for CYP2E1 inhibited group. Significant difference compared with other groups, P < 0.05. ∗∗Extremely significant difference compared with other groups, P < 0.01.